Literature DB >> 21859841

NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosis.

Rebecca Berger1, Claudia Jennewein, Viola Marschall, Sabine Karl, Silvia Cristofanon, Liane Wagner, Sri HariKrishna Vellanki, Stephanie Hehlgans, Franz Rödel, Klaus-Michael Debatin, Albert C Ludolph, Simone Fulda.   

Abstract

Evasion of apoptosis contributes to radioresistance of glioblastoma, calling for novel strategies to overcome apoptosis resistance. In this study, we investigated the potential of the small molecule Smac mimetic BV6 to modulate radiosensitivity of glioblastoma cells. Here, we identify a novel proapoptotic function of NF-κB in γ-irradiation-induced apoptosis of glioblastoma cells by showing, for the first time, that NF-κB is critically required for Smac mimetic-mediated radiosensitization. BV6 significantly increases γ-irradiation-triggered apoptosis in several glioblastoma cell lines in a dose- and time-dependent manner. Calculation of combination index (CI) reveals that the interaction of BV6 and γ-irradiation is highly synergistic (CI < 0.3). Molecular studies show that BV6 stimulates NF-κB activation, which is critical for radiosensitization, because genetic inhibition of NF-κB by overexpression of the dominant-negative superrepressor IκBα-SR significantly decreases BV6- and γ-irradiation-induced apoptosis. Also, the BV6-mediated enhancement of γ-irradiation-triggered caspase activation, drop of mitochondrial membrane potential, and cytochrome c release is abolished in cells overexpressing IκBα-SR. Similarly, NF-κB inhibition by ectopic expression of a kinase dead mutant of IKKβ prevents the BV6-mediated sensitization for γ-irradiation. The clinical relevance is underscored by experiments with primary tumor samples showing that BV6 sensitizes primary cultured glioma cells as well as glioblastoma-initiating cancer stem cells derived from surgical specimens for γ-irradiation. In conclusion, we identify NF-κB as a critical mediator of Smac mimetic-conferred radiosensitization of glioblastoma cells. These results have important implications for the development of Smac mimetic-based combination protocols for radiosensitization of glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859841     DOI: 10.1158/1535-7163.MCT-11-0218

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  32 in total

1.  Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.

Authors:  Li Sun; Hong-xiang Wang; Xiao-jian Zhu; Pin-hui Wu; Wei-qun Chen; Ping Zou; Qiu-bai Li; Zhi-chao Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-30       Impact factor: 6.150

Review 2.  Targeting IAP proteins for therapeutic intervention in cancer.

Authors:  Simone Fulda; Domagoj Vucic
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

3.  Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.

Authors:  A Tchoghandjian; C Jennewein; I Eckhardt; S Momma; D Figarella-Branger; S Fulda
Journal:  Cell Death Differ       Date:  2014-01-31       Impact factor: 15.828

4.  H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells.

Authors:  Priscilla S Redd; Chunwan Lu; John D Klement; Mohammed L Ibrahim; Gang Zhou; Takumi Kumai; Esteban Celis; Kebin Liu
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

5.  CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.

Authors:  Abdelkader E Ashour; Shazia Jamal; Vino T Cheryan; Magesh Muthu; Khairy M A Zoheir; Ahmed M Alafeefy; Adel R Abd-Allah; Edi Levi; Adi L Tarca; Lisa A Polin; Arun K Rishi
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 6.  Targeting IAP proteins in combination with radiotherapy.

Authors:  Simone Fulda
Journal:  Radiat Oncol       Date:  2015-04-26       Impact factor: 3.481

7.  Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response.

Authors:  I Eckhardt; A Weigert; S Fulda
Journal:  Cell Death Dis       Date:  2014-12-11       Impact factor: 8.469

8.  Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy.

Authors:  Jan Lewerenz; Paul Baxter; Rebecca Kassubek; Philipp Albrecht; Joeri Van Liefferinge; Mike-Andrew Westhoff; Marc-Eric Halatsch; Georg Karpel-Massler; Paul J Meakin; John D Hayes; Eleonora Aronica; Ilse Smolders; Albert C Ludolph; Axel Methner; Marcus Conrad; Ann Massie; Giles E Hardingham; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

9.  Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.

Authors:  A Tchoghandjian; C Jennewein; I Eckhardt; K Rajalingam; S Fulda
Journal:  Cell Death Dis       Date:  2013-03-28       Impact factor: 8.469

10.  The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.

Authors:  Stephanie Hehlgans; Julius Oppermann; Sebastian Reichert; Simone Fulda; Claus Rödel; Franz Rödel
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.